PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine

Inquiry

Cat. No.: X25-06-LY636

1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine

Synonym: 2095417-39-1; (2R,3R,4R,5R)-2-(Hydroxymethyl)-5-imidazo[2,1-f]purin-3-yloxolane-3,4-diol; 1,6N-Ethenoadenosine; 1,N6-Etheno-9-(|A-D-xylofuranosyl)adenosine; 1,N6-Etheno-9-(beta-D-xylofuranosyl)adenosine

CAS Number: 2095417-39-1
Compound CID: 14402353

Product Size

50 mg; 100 mg; 250 mg; 500 mg

Price

Datasheet

MSDS

Properties

Description

1,N6-Etheno-9-(β-D-xylofuranosyl)adenosineis characterized by the etheno modification at the N6 position of adenine, which alters base pairing properties. The β-D-xylofuranosyl sugar introduces rigidity to the structure, potentially impacting its interaction with nucleic acids and biological targets.

Molecular Weight

291.26

Molecular Formula

C₁₂H₁₃N₅O₄

Form

Solid

Purity

≥95.0%

Applications

1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is often used in metabolic research, especially in tumor cell metabolism and RNA studies, and can help understand the impact of nucleic acid structure on gene expression.

Publications

Publications (0)

Publications

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.